Staphylococcus aureus Nasal Carriage and Infection in Patients on Hemodialysis

New England Journal of Medicine

Volumn 315, Issue 2, 1986, Pages 91-96

  yu, Victor L ^a,b   Goetz, Angella ^a,b   Wagener, Marilyn ^a,b   Smith, Peter B ^a,b   Rihs, John D ^a,b   Hanchett, James ^a,b   Zuravleff, Jeffrey J ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; HEMODIALYSIS FLUID; PLACEBO; RIFAMPICIN; VANCOMYCIN;

BLOOD AND HEMOPOIETIC SYSTEM; CARDIOVASCULAR SYSTEM; CARRIER; CLINICAL ARTICLE; DRUG THERAPY; EPIDEMIOLOGY; HEMODIALYSIS; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; NOSE; ORAL DRUG ADMINISTRATION; PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; STAPHYLOCOCCUS AUREUS; THERAPY; TOPICAL DRUG ADMINISTRATION; VASCULAR ACCESS;

ADMINISTRATION, INTRANASAL; ANTI-BACTERIAL AGENTS; BACITRACIN; BACTERIOPHAGE TYPING; CARRIER STATE; CLINICAL TRIALS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; HUMANS; INJECTIONS, INTRAVENOUS; NOSE; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RENAL DIALYSIS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 0022578673     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198607103150204     Document Type: Article

References (34)

1. Cross AS, Steigbigel RT. Infective endocarditis and access site infections in patients on hemodialysis. Medicine (Baltimore) 1976; 55: 453–66.
2. Siddiqui JY, Fitz AE, Lawton RL, et al. Causes of death in patients receiving long-term hemodialysis. JAMA 1970; 212: 1350–4.
3. Lowrie EG, Lazarus JM, Mocelin AJ, et al. Survival of patients undergoing chronic hemodialysis and renal transplantation. N Engl J Med 1973; 288: 863–7.
4. Dobkin JF, Miller MH, Steigbigel NH. Septicemia in patients on chronic hemodialysis. Ann Intern Med 1978; 88: 28–33.
5. Appel GB. Vascular access infections with long-term hemodialysis: the dialysis staff versus the dialysis staph. Arch Intern Med 1978; 138: 1609–10.
6. Goldblum SE, Reed WP, Ulrich JA, Goldman RS. Staphylococcal carriage and infections in hemodialysis patients. Dial Transplant 1978; 7: 1140–8.
7. Linnemann CC Jr, McKee E, Laver MC. Staphylococcal infections in a hemodialysis unit. Am J Med Sci 1978; 276: 67–75.
8. Francioli P, Masur H. Complications of Staphylococcus aureus bacteremia: occurrence in patients undergoing long-term hemodialysis. Arch Intern Med 1982; 142: 1655–8.
9. Kirmani N, Tuazon CU, Murray HW, Parrish AE, Sheagren JN. Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis. Arch Intern Med 1978; 138: 1657–9.
10. Noble WC, Rebel MH, Smith I. An investigation of the skin flora of dialysis and transplant patients. Br J Dermatol 1974; 91: 201–7.
11. Rebel MH, Van Furth R, Stevens P, Bosscher-Zonderman L, Noble WC. The flora of renal haemodialysis shunt sites. J Clin Pathol 1975; 28: 29–32.
12. Tulloch LG. Nasal carriage in staphylococcal skin infections. Br Med J 1954; 2: 912–3.
13. Solberg CO. A study of carriers of Staphylococcus aureus with special regard to quantitative bacterial estimations. Acta Med Scand [Suppl] 1965; 436: 1–96.
14. White A. Increased infection rates in heavy nasal carriers of coagulase-positive staphylococci. Antimicrob Agents Chemother 1963; 3: 667–70.
15. Weinstein HJ. The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications. N Engl J Med 1959; 260: 1303–8.
16. Nahmias AJ, Shulman J. Epidemiology of staphylococci. In: Cohen JO, ed. The staphylococci. New York: John Wiley, 1972:486–502.
17. Martin AM, Clunie GJ, Tonkin RW, Robson JS. The aetiology and management of shunt infections in patients on intermittent hemodialysis. Proc Eur Dial Transplant Assoc 1967; 4: 67–72.
18. Ralston AJ, Harlow GR, Jones DM, Davis P. Infections of Scribner and Brescia arteriovenous shunts. Br Med J 1971; 3: 408–9.
19. Blair JE, Carr M. The bacteriophage typing of staphylococci. J Infect Dis 1953; 93: 1–13.
20. Smith PB. Bacteriophage typing of Staphylococcus aureus. In: Cohen JO, ed. The staphylococci. New York: John Wiley, 1972:431–41.
21. Dathan JRE, Frankel RJ, Goodwin FJ, et al. One year's experience in a Ministry of Health dialysis centre. Br Med J 1970; 2: 102–5.
22. Morris AJ, Bilinsky RT. Prevention of staphylococcal shunt infections by continuous vancomycin prophylaxis. Am J Med Sci 1971; 262: 87–92.
23. Wheat LJ, Kohler RB, White AL, White A. Effect of rifampin on nasal carriage of coagulase-positive staphylococci. J Infect Dis 1981; 144: 177.
24. Williams JD, Waltho CA, Ayliffe GAJ, Lowbury EJL. Trials of five antibacterial creams in the control of nasal carriage of Staphylococcus aureus. Lancet 1967; 2: 390–2.
25. Weinstein HJ. Control of nasal-staphylococcal-carrier states. N Engl J Med 1959; 260: 1308–10.
26. Stokes EJ, Milne SE. Effect of Naseptin cream prophylaxis on staphylococcal infection in adult surgical wards and infant nurseries. J Hyg (Camb) 1962; 60: 209–15.
27. McAnally TB, Lewis MR, Brown DR. Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus. Antimicrob Agents Chemother 1984; 25: 422–6.
28. Bryan CS, Wilson RS, Meade P, Sill LG. Topical antibiotic ointments for staphylococcal nasal carriers: survey of current practices and comparison of bacitracin and vancomycin ointments. IC Infect Control 1980; 1: 153–6.
29. White A. The use of gentamicin as a nasal ointment. Am J Med Sci 1964; 248: 52–5.
30. Ellison RT III, Judson FN, Peterson LC, Cohn DL, Ehret JM. Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections. West J Med 1984; 140: 735–40.
31. Ward TT, Winn RE, Hartstein AI, Sewell DL. Observations relating to an inter-hospital outbreak of methicillin-resistant Staphylococcus aureus: role of antimicrobial therapy in infection control. IC Infect Control 1981; 2: 453–9.
32. Knight V, White achéal, Martin MP. The effect of antimicrobial drugs on the staphylococcal flora of hospital patients. Ann Intern Med 1958; 49: 536–43.
33. Goldblum SE, Ulrich JA, Goldman RS, Reed WP. Nasal and cutaneous flora among hemodialysis patients and personnel: quantitative and qualitative characterization and patterns of staphylococcal carriage. Am J Kidney Dis 1982; 2: 281–6.
34. Sande MA, Mandell GL. Effect of rifampin on nasal carriage of Staphylococcus aureus. Antimicrob Agents Chemother 1975; 7: 294–7.